Text Size
2930 studies found for:    Blood Coagulation Disorders: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: NNC 0129-0000-1003
22 Completed Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B
Interventions: Drug: activated recombinant human factor VII;   Drug: activated recombinant human factor VII analogue
23 Completed Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
Conditions: Congenital Bleeding Disorder;   Congenital FVII Deficiency;   Glanzmann's Disease;   Acquired Bleeding Disorder;   Acquired Haemophilia
Intervention: Drug: activated recombinant human factor VII
24 Completed Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: 40K PEG-rFIX
25 Completed Anticoagulant Clinics and Vitamin K Antagonists
Condition: Blood Coagulation Disorders
Intervention: Drug: Anticoagulant (warfarin, acenocoumarol, fluindione)
26 Completed Study of Abnormal Blood Clotting in Children With Stroke
Conditions: Abnormalities;   Blood Coagulation Disorder;   Brain Disease;   Cerebrovascular Accident;   Vascular Disease
Intervention:
27 Recruiting Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Condition: HIV-1 Infection
Intervention: Drug: atorvastatin
28 Completed Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery
Conditions: Congenital Bleeding Disorder;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors
Intervention: Drug: eptacog alfa (activated)
29 Completed Safety and Efficacy of N8 in Haemophilia A Subjects
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Interventions: Drug: recombinant factor VIII (N8);   Procedure: Blood drawn for laboratory testing
30 Completed Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice
Conditions: Congenital Bleeding Disorder;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors
Intervention: Drug: eptacog alfa (activated)
31 Recruiting A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: NNC 0129-0000-1003
32 Completed Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency;   Healthy
Intervention: Drug: recombinant factor XIII
33 Not yet recruiting Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze
Conditions: Bleeding;   Coagulopathy
Intervention: Device: pad-gauze with tranexamic acid (Hemostopan™)
34 Not yet recruiting Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
Condition: Coagulation Defects
Interventions: Biological: Spray-dried S/D-treated Plasma;   Drug: Spray-dried S/D-treated plasma
35 Completed Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
Conditions: Coronary Heart Disease;   Coagulation Disorder
Intervention: Drug: Anfibatide
36 Not yet recruiting Point-of-Care Testing in Coagulopathic Patients Undergoing Cardiac Surgery - a Multicenter Study
Condition: Coagulopathy During Cardiac Surgery
Interventions: Device: Conventional laboratory testing (Central laboratory);   Device: POC testing
37 Completed Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
Condition: Clotting Disorders
Intervention:
38 Completed A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B;   Healthy
Interventions: Drug: activated recombinant human factor VII, long acting;   Drug: placebo
39 Recruiting Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: NNC-0156-0000-0009
40 Completed Treatment of Congenital Factor VII Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FVII Deficiency
Interventions: Drug: activated recombinant human factor VII;   Drug: Fresh frozen plasma (Source unspecified);   Drug: Plasma-derived FVII (LFB);   Drug: Prothrombin Complex conc. (PCC);   Drug: Plasma-derived FVII conc. (pdFVII Baxter);   Drug: Plasma-derived FVII conc. (pdFVII PFL)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years